In Silico Design and Analysis of Cyanobacterial Pseudo Natural Products
- 16 July 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of Natural Products
- Vol. 88 (7) , 1701-1709
Abstract
Marine cyanobacteria produce natural products (NPs) with potent and selective bioactivity against a broad range of diseases. However, like many NPs, most exhibit poor drug-like physicochemical properties, and the discovery of structurally novel NPs is declining. To address these challenges, we generated an in silico library of 2,415 cyanobacterial pseudo-NPs by tethering cyanobacterial NP fragments with privileged scaffolds from noncyanobacterial NPs via hypothetical amide bond formation. This library was analyzed using computational platforms to assess predicted physicochemical and ADME/Tox properties, lead-likeness penalties, NP-likeness scores, Tanimoto similarity coefficients, and Synthetic Accessibility Scores. Comparisons to public compound libraries showed that most cyanobacterial pseudo-NPs possess favorable drug- and lead-like characteristics; occupy low-density chemical space; and display unique, synthetically accessible scaffolds. Our results suggest that these pseudo-NPs are promising synthetic targets for drug development. Moreover, this platform can be expanded by using artificial intelligence (AI)-based fragment harvesting tools to create larger libraries of NP-inspired compounds. By integrating cyanobacterial fragments with known bioactive motifs, we aim to bridge the gap between natural diversity and drug-like properties, providing a novel and tractable chemical space for drug discovery efforts.Keywords
All Related Versions
Funding Information
- American Society of Pharmacognosy
- National Institute on Minority Health and Health Disparities (U54 MD007600)
- National Institute of General Medical Sciences (3T34GM007821, SC2GM144152)
This publication has 61 references indexed in Scilit:
- Development of Potent and Highly Selective Epoxyketone‐Based Plasmodium Proteasome InhibitorsChemistry – A European Journal, 2023
- MolPredictX: Online Biological Activity Predictions by Machine Learning ModelsMolecular Informatics, 2022
- Pseudo Natural Products—Chemical Evolution of Natural Product StructureAngewandte Chemie International Edition, 2021
- Syntheses of Thailandepsin B Pseudo‐Natural Products: Access to New Highly Potent HDAC Inhibitors via Late‐Stage ModificationChemistry – A European Journal, 2020
- Natural product derived privileged scaffolds in drug discoveryCurrent Opinion in Chemical Biology, 2019
- Synthesis of Indomorphan Pseudo‐Natural Product Inhibitors of Glucose Transporters GLUT‐1 and ‐3Angewandte Chemie, 2019
- Apratoxin Kills Cells by Direct Blockade of the Sec61 Protein Translocation ChannelCell Chemical Biology, 2016
- Privileged scaffolds for library design and drug discoveryCurrent Opinion in Chemical Biology, 2010
- Drug discovery beyond the ‘rule-of-five’Current Opinion in Biotechnology, 2007
- Total Synthesis of the Cyclodepsipeptide Apratoxin A and Its Analogues and Assessment of Their Biological ActivitiesChemistry – A European Journal, 2006